Authors


Ajay Pazhayattil

Latest:

Lifecycle-Based Process Validation Emphasizes the Need for Continued Process Verification

A year’s worth of FDA warning letters suggest that API and finished drug manufacturers should strengthen their approach to continued process verification.


Chetan Doshi

Latest:

A Continuous Improvement Metric for Pharmaceutical Manufacturing

Statistical methods and novel indices can be used to monitor and benchmark variability, and guide continuous improvement programs in late-stage drug development.


Walt Murray

Latest:

Avoiding Investigational Failure/Discrepancy-Related Form 483 Observations

Investigational failures and discrepancies can be avoided through the proper execution and documentation of investigations.






Spencer Miller

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


Stephen Hunt

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


John Robinson

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


Laurence T. Baxter

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


Bob Todd

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


Amber Lowry

Latest:

Innovations Maintain the Cold Chain

Recent advancements in cold-chain technology offer improved transporting and storing of temperature-sensitive pharmaceutical products.


Vince Russell

Latest:

Four Challenges for Pulmonary Drug Delivery

Pulmonary drug delivery is becoming increasingly used. When developing pulmonary drugs, pharmaceutical chemists must consider drug absorption, control of particle size, suitable toxicology models, and patient compliance. The author reviews the issues specific to developing drugs designed for pulmonary delivery and considers how-with the right knowledge and expertise-these challenges can be overcome.


Graham A. McGibbon

Latest:

Applying QbD in Process Development

Informatics software can be used to address the challenges of quality by design, such as managing impurity data when developing an impurity control strategy.


Sanjivanjit K. Bhal

Latest:

Applying QbD in Process Development

Informatics software can be used to address the challenges of quality by design, such as managing impurity data when developing an impurity control strategy.


Andrew Anderson

Latest:

Applying QbD in Process Development

Informatics software can be used to address the challenges of quality by design, such as managing impurity data when developing an impurity control strategy.


Carolina Diaz Quijano

Latest:

A Multifunctional Mineral Excipient

Functionalized calcium carbonate provides high porosity, which enables fast disintegration, and excellent compactibility that results in harder tablets at low compression forces.


Hildegard Bruemmer

Latest:

Early Efforts Identify Unstable APIs

Forced degradation tests, conducted in early development stages, can provide insight into degradation pathways and products of a drug substance.


Wolfgang Schiemenz

Latest:

QbD: Improving Pharmaceutical Development and Manufacturing Workflows to Deliver Better Patient Outcomes

Implementing quality by design in product design and formulation and manufacturing workflows can help improve efficiency and shorten development times.


Michael Larson

Latest:

Quality by Design: A CMO's Perspective on Gaining Knowledge Faster and Better

Traditional project decision-making is compared with a QbD approach.


Christopher J. Murray

Latest:

Industrializing Design, Development, and Manufacturing of Therapeutic Proteins

The authors discuss various approaches and related issues, including production of difficult-to express proteins using cell-free expression systems, scalability of protein expression, and site-specific chemical modifications.


Valere Logel

Latest:

Why Bottles with Desiccant Outperform Foil-Foil Blister Packaging

While cold-form, foil-foil (aluminumaluminum) blister packaging is considered the most moisture-protective packaging available, in fact, plastic containers such as bottles and tubes, when combined with desiccants, such as silica gel canisters and packets, will often provide lower internal relative humidity for long time periods.


Stephane Rault

Latest:

Why Bottles with Desiccant Outperform Foil-Foil Blister Packaging

While cold-form, foil-foil (aluminumaluminum) blister packaging is considered the most moisture-protective packaging available, in fact, plastic containers such as bottles and tubes, when combined with desiccants, such as silica gel canisters and packets, will often provide lower internal relative humidity for long time periods.


Aurelie Emond

Latest:

Why Bottles with Desiccant Outperform Foil-Foil Blister Packaging

While cold-form, foil-foil (aluminumaluminum) blister packaging is considered the most moisture-protective packaging available, in fact, plastic containers such as bottles and tubes, when combined with desiccants, such as silica gel canisters and packets, will often provide lower internal relative humidity for long time periods.


Kenneth C. Waterman, PhD

Latest:

Why Bottles with Desiccant Outperform Foil-Foil Blister Packaging

While cold-form, foil-foil (aluminumaluminum) blister packaging is considered the most moisture-protective packaging available, in fact, plastic containers such as bottles and tubes, when combined with desiccants, such as silica gel canisters and packets, will often provide lower internal relative humidity for long time periods.


Mark Florez

Latest:

Why Bottles with Desiccant Outperform Foil-Foil Blister Packaging

While cold-form, foil-foil (aluminumaluminum) blister packaging is considered the most moisture-protective packaging available, in fact, plastic containers such as bottles and tubes, when combined with desiccants, such as silica gel canisters and packets, will often provide lower internal relative humidity for long time periods.


Joanne Sullivan

Latest:

How to Get the Most from Regulatory Outsourcing

Regulatory outsourcing can result in improved compliance, greater transparency, higher productivity, increased cost-effectiveness, and desired strategic outcomes.


Philip Smith

Latest:

How to Get the Most from Regulatory Outsourcing

Regulatory outsourcing can result in improved compliance, greater transparency, higher productivity, increased cost-effectiveness, and desired strategic outcomes.


Bettina Goldberg

Latest:

How to Get the Most from Regulatory Outsourcing

Regulatory outsourcing can result in improved compliance, greater transparency, higher productivity, increased cost-effectiveness, and desired strategic outcomes.